Insilico Medicine and Hygtia Therapeutics Enter New Global Strategic Collaboration to Co-Develop Novel Brain Penetrant NLRP3 Inhibitor for CNS Diseases treatment
Insilico Medicine and Hygtia Therapeutics, an incubatee of Shenzhen Pengfu Fund of Fosun Health Capital and Fosun Pharma, have entered into an exclusive license and co-development collaboration to advance ISM8969 worldwide. Under the agreement, both...
HD Hyundai Chairman Chung Kisun Discusses Future of AI and Energy at Davos Forum
Chairman Chung attends 2026 World Economic Forum Annual Meeting for fourth consecutive year Discusses AI-driven transformation and innovation in energy transition at key sessions Met with Palantir co-founder and CEO Alex Karp to discuss expansion of...
T.D. Williamson launches SHiiELD™ double independent isolation and bleed system
TULSA, Okla., Jan. 21, 2026 /PRNewswire/ -- T.D. Williamson (TDW), a global leader in pipeline solutions, announced the launch of TDW SHiiELD™, a next-generation pipeline isolation tool creating a new standard of double independent isolation and...
InfoComm China 20th Anniversary: Celebrating Two Decades as Asia's Most Influential and Professional Pro-AV Showcase
BEIJING, Jan. 21, 2026 /PRNewswire/ -- For 20 years, Beijing InfoComm China has served as the most professional and influential platform for promoting and expanding China's global Professional Audio-Visual (Pro-AV) industry. Through decades of...
North London Collegiate School (Singapore) celebrates the Wheelchair Rugby Association Singapore (WRAS) athletes participating in the upcoming ASEAN Para Games
SINGAPORE, Jan. 21, 2026 /PRNewswire/ -- The partnership between NLCS (Singapore) and the Wheelchair Rugby Association Singapore began through the initiative of an NLCS (Singapore) student who, after becoming involved with the association, learned...
Nanoscope Secures Japan MHLW Sakigake and Orphan Drug Designations Across Inherited Retinal Diseases - A First for a Retinal Gene Therapy
Japan's Ministry of Health, Labour and Welfare (MHLW) grants MCO-010 Sakigake (Pioneering Regenerative Medical Product) and Orphan Drug designations, enabling an accelerated regulatory pathway for patients with severe inherited retinal diseases...
Amcor to report fiscal 2026 second quarter and half year results
ZURICH, Jan. 21, 2026 /PRNewswire/ -- Amcor plc (NYSE: AMCR; ASX: AMC) will announce its fiscal 2026 second quarter and half year result for the three and sixth month period ended 31 December 2025 after the US market closes on Tuesday 3 February...
Video: U.S. AI Advisor Sacks Highlights UAE and G42 as Critical Partners in U.S. AI Competitiveness
Momentum builds behind AI partnership following last year's announcement of a 5GW UAE–US AI Campus and chip approvals as leaders meet in Davos DAVOS, Switzerland, Jan. 21, 2026 /PRNewswire/ -- Today, on the sidelines of the World Economic Forum...